SI1904029T2 - Oralni, hitro razpadajoäśi film, ki se ne da izpljuniti, vsebujoäś olanzapin - Google Patents
Oralni, hitro razpadajoäśi film, ki se ne da izpljuniti, vsebujoäś olanzapinInfo
- Publication number
- SI1904029T2 SI1904029T2 SI200630958T SI200630958T SI1904029T2 SI 1904029 T2 SI1904029 T2 SI 1904029T2 SI 200630958 T SI200630958 T SI 200630958T SI 200630958 T SI200630958 T SI 200630958T SI 1904029 T2 SI1904029 T2 SI 1904029T2
- Authority
- SI
- Slovenia
- Prior art keywords
- olanzapin
- oral
- spit out
- disintegrating film
- quickly disintegrating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005033943A DE102005033943A1 (de) | 2005-07-20 | 2005-07-20 | Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum |
EP06776333.4A EP1904029B2 (de) | 2005-07-20 | 2006-07-20 | Nicht-ausspuckbarer, oraler, schnell-zerfallender film enthaltend olanzapin |
PCT/EP2006/007177 WO2007009801A2 (de) | 2005-07-20 | 2006-07-20 | Nicht-ausspuckbarer, oraler, schnell-zerfallender film für ein neuroleptikum |
Publications (2)
Publication Number | Publication Date |
---|---|
SI1904029T1 SI1904029T1 (sl) | 2011-04-29 |
SI1904029T2 true SI1904029T2 (sl) | 2015-01-30 |
Family
ID=37156035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200630958T SI1904029T2 (sl) | 2005-07-20 | 2006-07-20 | Oralni, hitro razpadajoäśi film, ki se ne da izpljuniti, vsebujoäś olanzapin |
Country Status (18)
Country | Link |
---|---|
US (1) | US20080200452A1 (sl) |
EP (1) | EP1904029B2 (sl) |
JP (1) | JP5551361B2 (sl) |
CN (1) | CN101287445A (sl) |
AT (1) | ATE496616T1 (sl) |
AU (1) | AU2006271865B2 (sl) |
BR (1) | BRPI0613683A2 (sl) |
CA (1) | CA2615533C (sl) |
DE (2) | DE102005033943A1 (sl) |
ES (1) | ES2358607T5 (sl) |
HK (1) | HK1112843A1 (sl) |
MX (1) | MX2008000847A (sl) |
PL (1) | PL1904029T5 (sl) |
PT (1) | PT1904029E (sl) |
RU (1) | RU2427374C2 (sl) |
SI (1) | SI1904029T2 (sl) |
WO (1) | WO2007009801A2 (sl) |
ZA (1) | ZA200800976B (sl) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009099830A2 (en) * | 2008-01-31 | 2009-08-13 | Mcneil-Ppc, Inc. | Edible film-strips for immediate release of active ingredients |
EP2674150A1 (de) * | 2009-01-28 | 2013-12-18 | Labtec GmbH | Pharmazeutische Zubereitung mit verbesserter Stabilität des Wirkstoffs |
WO2010086989A1 (ja) | 2009-01-29 | 2010-08-05 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
JP5751868B2 (ja) | 2010-03-30 | 2015-07-22 | 日東電工株式会社 | フィルム状製剤及びその製造方法 |
WO2011138049A1 (de) | 2010-05-07 | 2011-11-10 | Hexal Aktiengesellschaft | Mucosaler film enthaltend zwei zuckeraustauschstoffe |
DE102010049706A1 (de) | 2010-10-28 | 2012-05-03 | Hexal Ag | Herstellung orodispersibler Filme |
DE102010049708A1 (de) | 2010-10-28 | 2012-05-03 | Hexal Ag | Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe |
EP2486913A1 (en) | 2011-02-14 | 2012-08-15 | Labtec GmbH | Rapidly disintegrating oral film formulation for Olanzapin |
JP5257804B1 (ja) * | 2011-12-09 | 2013-08-07 | Dic株式会社 | 造膜助剤ならびにそれを含有する水性樹脂組成物及び鋼板表面処理剤 |
JP5841433B2 (ja) | 2012-01-11 | 2016-01-13 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
CN102920683B (zh) * | 2012-06-11 | 2013-08-14 | 江苏豪森药业股份有限公司 | 奥氮平口腔速溶膜 |
WO2014135967A1 (en) | 2013-03-06 | 2014-09-12 | Capsugel Belgium Nv | Curcumin solid lipid particles and methods for their preparation and use |
EP3766480A1 (en) * | 2014-06-10 | 2021-01-20 | Capsugel Belgium NV | Orally disintegrating tablet containing solid lipid particles and methods for their preparation and use |
JP6748642B2 (ja) * | 2014-06-24 | 2020-09-02 | リー,キヤサリン | 即効性口腔崩壊フィルム |
AU2015289150B2 (en) | 2014-07-17 | 2020-10-15 | Hexal Ag | Orodispersible film |
US11324699B2 (en) | 2014-12-04 | 2022-05-10 | Capsugel Belgium Nv | Lipid multiparticulate formulations |
US20170216220A1 (en) * | 2016-02-03 | 2017-08-03 | Intelgenx Corp. | Loxapine film oral dosage form |
US11648212B2 (en) * | 2016-02-03 | 2023-05-16 | Intelgenx Corp. | Loxapine film oral dosage form |
DE102017103346A1 (de) | 2017-02-17 | 2018-08-23 | Lts Lohmann Therapie-Systeme Ag | Strukturierte orodispergierbare Filme |
CN107823191B (zh) * | 2017-11-16 | 2021-04-09 | 广州迈达康医药科技有限公司 | 一种帕利哌酮口服速溶膜制剂及其制备工艺 |
GR20200100430A (el) * | 2020-06-01 | 2022-01-13 | Κυριακος Ηλια Κυπραιος | Ταχεως διαλυομενες στοματικες ταινιες για τη χορηγηση δια της στοματικης οδου φαρμακων και λοιπων βιοδραστικων ουσιων σε ανθρωπους |
KR102501784B1 (ko) * | 2020-11-02 | 2023-02-20 | 아주대학교산학협력단 | 난용성 약물을 포함하는 구강 붕해 필름 제조방법 |
US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4317214A (en) * | 1980-07-14 | 1982-02-23 | Attinello John S | Apparatus for simulating interference transmissions |
GB8426152D0 (en) * | 1984-10-16 | 1984-11-21 | Reckitt & Colmann Prod Ltd | Medicinal compositions |
USRE33093E (en) * | 1986-06-16 | 1989-10-17 | Johnson & Johnson Consumer Products, Inc. | Bioadhesive extruded film for intra-oral drug delivery and process |
US4820506A (en) * | 1987-05-01 | 1989-04-11 | Research Foundation, State University Of New York | Salivary stimulant |
JPH03232817A (ja) * | 1990-02-07 | 1991-10-16 | Showa Yakuhin Kako Kk | 貼付剤 |
DE4018247A1 (de) * | 1990-06-07 | 1991-12-12 | Lohmann Therapie Syst Lts | Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen |
US5958458A (en) * | 1994-06-15 | 1999-09-28 | Dumex-Alpharma A/S | Pharmaceutical multiple unit particulate formulation in the form of coated cores |
US5891461A (en) * | 1995-09-14 | 1999-04-06 | Cygnus, Inc. | Transdermal administration of olanzapine |
US5766620A (en) * | 1995-10-23 | 1998-06-16 | Theratech, Inc. | Buccal delivery of glucagon-like insulinotropic peptides |
US5955097A (en) * | 1996-10-18 | 1999-09-21 | Virotex Corporation | Pharmaceutical preparation applicable to mucosal surfaces and body tissues |
DE19646392A1 (de) * | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
US20050048102A1 (en) * | 1997-10-16 | 2005-03-03 | Virotex Corporation | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
US6103266A (en) * | 1998-04-22 | 2000-08-15 | Tapolsky; Gilles H. | Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues |
AU3478200A (en) * | 1999-02-02 | 2000-08-25 | Ortho-Mcneil Pharmaceutical, Inc. | Method of manufacture for transdermal matrices |
CA2371940C (en) * | 1999-03-31 | 2008-07-15 | Janssen Pharmaceutica N.V. | Pregelatinized starch in a controlled release formulation |
US6264981B1 (en) * | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
US20030124176A1 (en) * | 1999-12-16 | 2003-07-03 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
US7067116B1 (en) * | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
US6828308B2 (en) * | 2000-07-28 | 2004-12-07 | Sinclair Pharmaceuticals, Ltd. | Compositions and methods for the treatment or prevention of inflammation |
JP2002338456A (ja) * | 2001-05-14 | 2002-11-27 | ▲高▼田 ▲寛▼治 | 小腸粘膜付着性貼付剤Gastrointestinalmucoadhesivepatchsystem(GI−MAPS)の製造法 |
JP2003125679A (ja) * | 2001-10-19 | 2003-05-07 | Shimano Inc | ベイトリール |
US20040247649A1 (en) * | 2002-02-11 | 2004-12-09 | Edizone, Lc | Medicine-containing orally soluble films |
JP2004043450A (ja) * | 2002-05-16 | 2004-02-12 | Kyukyu Yakuhin Kogyo Kk | 速溶性フィルム状製剤 |
EP1413887A1 (en) * | 2002-10-22 | 2004-04-28 | Aventis Pharma S.A. | Inhibitors of Src kinase for use in Alzheimer's disease |
CA2504283A1 (en) * | 2002-10-31 | 2004-05-21 | Umd, Inc. | Therapeutic compositions for drug delivery to and through covering epithelia |
JP4443903B2 (ja) * | 2002-12-02 | 2010-03-31 | 救急薬品工業株式会社 | 積層フィルム状可食性口腔内投与剤の製造方法 |
US20040265375A1 (en) * | 2003-04-16 | 2004-12-30 | Platteeuw Johannes J. | Orally disintegrating tablets |
BRPI0409463A (pt) * | 2003-05-02 | 2006-05-02 | Warner Lambert Co | pelìculas consumìveis oralmente de dissolução rápida contendo um amido modificado para melhorar a resistência ao calor e à umidade |
DK2446881T3 (da) * | 2003-07-24 | 2014-06-02 | Glaxosmithkline Llc | Oral opløselige film |
JP2007502823A (ja) * | 2003-08-15 | 2007-02-15 | キューエルティー・ユーエスエイ・インコーポレーテッド | 接着性および生体侵食性の経粘膜薬物送達システム |
CA2543350C (en) * | 2003-10-24 | 2011-04-26 | Adhesives Research, Inc. | Disintegratable films for diagnostic devices |
-
2005
- 2005-07-20 DE DE102005033943A patent/DE102005033943A1/de not_active Ceased
-
2006
- 2006-07-20 RU RU2008105830/15A patent/RU2427374C2/ru not_active IP Right Cessation
- 2006-07-20 CA CA2615533A patent/CA2615533C/en not_active Expired - Fee Related
- 2006-07-20 ZA ZA200800976A patent/ZA200800976B/xx unknown
- 2006-07-20 US US11/996,382 patent/US20080200452A1/en not_active Abandoned
- 2006-07-20 PT PT06776333T patent/PT1904029E/pt unknown
- 2006-07-20 AT AT06776333T patent/ATE496616T1/de active
- 2006-07-20 MX MX2008000847A patent/MX2008000847A/es active IP Right Grant
- 2006-07-20 BR BRPI0613683-4A patent/BRPI0613683A2/pt not_active IP Right Cessation
- 2006-07-20 SI SI200630958T patent/SI1904029T2/sl unknown
- 2006-07-20 AU AU2006271865A patent/AU2006271865B2/en not_active Ceased
- 2006-07-20 WO PCT/EP2006/007177 patent/WO2007009801A2/de active Application Filing
- 2006-07-20 ES ES06776333.4T patent/ES2358607T5/es active Active
- 2006-07-20 JP JP2008521902A patent/JP5551361B2/ja not_active Expired - Fee Related
- 2006-07-20 DE DE502006008816T patent/DE502006008816D1/de active Active
- 2006-07-20 PL PL06776333T patent/PL1904029T5/pl unknown
- 2006-07-20 CN CNA2006800345104A patent/CN101287445A/zh active Pending
- 2006-07-20 EP EP06776333.4A patent/EP1904029B2/de not_active Not-in-force
-
2008
- 2008-07-16 HK HK08107888.2A patent/HK1112843A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT1904029E (pt) | 2011-03-16 |
BRPI0613683A2 (pt) | 2011-01-25 |
WO2007009801A2 (de) | 2007-01-25 |
EP1904029B2 (de) | 2014-11-12 |
RU2008105830A (ru) | 2009-11-10 |
ES2358607T5 (es) | 2014-12-05 |
PL1904029T3 (pl) | 2011-06-30 |
AU2006271865A1 (en) | 2007-01-25 |
EP1904029A2 (de) | 2008-04-02 |
DE102005033943A1 (de) | 2007-02-22 |
HK1112843A1 (en) | 2008-09-19 |
ZA200800976B (en) | 2009-08-26 |
AU2006271865B2 (en) | 2011-08-25 |
CN101287445A (zh) | 2008-10-15 |
JP5551361B2 (ja) | 2014-07-16 |
RU2427374C2 (ru) | 2011-08-27 |
CA2615533C (en) | 2014-04-08 |
ATE496616T1 (de) | 2011-02-15 |
PL1904029T5 (pl) | 2015-05-29 |
ES2358607T3 (es) | 2011-05-12 |
US20080200452A1 (en) | 2008-08-21 |
EP1904029B1 (de) | 2011-01-26 |
WO2007009801A3 (de) | 2007-06-21 |
CA2615533A1 (en) | 2007-01-25 |
JP2009501752A (ja) | 2009-01-22 |
SI1904029T1 (sl) | 2011-04-29 |
MX2008000847A (es) | 2008-03-26 |
DE502006008816D1 (de) | 2011-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1112843A1 (en) | Oral, quickly disintegrating film, which cannot be spit out, containing olanzapin | |
WO2007009800A3 (de) | Nicht-ausspuckbarer, oraler, schnell-zerfallender film für antiemetikum oder antimigränemittel | |
WO2006081251A3 (en) | Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione | |
WO2007045252A3 (en) | An edible composition | |
MX343314B (es) | Composiciones liquidas ionicas multifuncionales para superar el polimorfismo y proporcionar propiedades mejoradas a los ingredientes farmaceuticos, biologicos, nutricionales y energeticos activos. | |
MX2008007307A (es) | Granulos/capsulas modificados que contienen ingrediente activo. | |
EP1919302B8 (en) | Food comprising silicon | |
WO2005041924A3 (en) | Administration of levodopa and carbidopa | |
WO2006045119A3 (en) | Improved inhibitors for the soluble epoxide hydrolase | |
EP2450360A3 (en) | (S)-N-Methylnaltrexone | |
WO2007064885A3 (en) | Oral care compositions, methods, devices and systems | |
NO20075009L (no) | Ernaeringstilsetning for HIV-pasienter | |
MX2007012623A (es) | Inulina de cadena larga. | |
EP2476461A3 (en) | Formulations For Cancer Treatment | |
EP2241196A3 (en) | Nutritional supplement comprising oligosaccharides and cysteine for treating hiv | |
UA88165C2 (en) | Use of trisubstituted benzopyranones | |
BRPI0506779A (pt) | formulação de sorvete, e, sorvete | |
WO2008046865A3 (en) | Long-term feed - elderly | |
MX2009003260A (es) | Probioticos para el uso en la reduccion de la incidencia y duracion de la enfermedad. | |
MX2007011264A (es) | Composiciones nutricionales para modular la biodisponibilidad de vitamina c. | |
SG165324A1 (en) | Compositions and methods to counteract oral malodour | |
WO2005052140A3 (en) | Multipotent postnatal stem cells from human periodontal ligament and uses thereof | |
MXPA05008902A (es) | Soluciones de drogas en mentol. | |
NO20051473D0 (no) | Behandling mot brekninger. | |
GB0327390D0 (en) | Pharmaceutical formulations |